Can an oral drug stop COVID-19 pneumonia from turning deadly?
Disease control
Cancelled
This trial tests whether the oral drug EC-18 can prevent mild or moderate COVID-19 pneumonia from progressing to severe pneumonia or acute respiratory distress syndrome (ARDS). Adults with confirmed COVID-19 pneumonia who do not yet need oxygen will receive either EC-18 or a plac…
Phase 2 • Sponsor: Enzychem Lifesciences Corporation • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC